Filing Details
- Accession Number:
- 0000912282-24-000829
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-26 18:56:32
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-26 18:56:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882361 | Aptose Biosciences Inc. | APTO | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761487 | G. William Rice | C/O Aptose Biosciences Inc. 251 Consumers Road, Suite 1105 Toronto A6 M2J 4R3 | Chair, President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-11-25 | 100,000 | $0.20 | 613,252 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Warrants | Acquisiton | 2024-11-25 | 50,000 | $0.00 | 50,000 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2024-11-25 | 2029-11-25 | No | 4 | P | Direct |
Footnotes
- Shares and warrants were acquired as part of an Issuer unit offering, each unit priced at $0.20 consisting of one common share and one-half of one common share purchase warrant.
Billionaire Hedge Funds
